Alfresa Holdings Corporation (TYO:2784)
Japan flag Japan · Delayed Price · Currency is JPY
2,165.50
+9.50 (0.44%)
Jul 29, 2025, 3:30 PM JST

Alfresa Holdings Company Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.

It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies.

The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.

In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals.

Further, the company’s medical-related business includes its dispensing pharmacy and other medical-related businesses.

The company was incorporated in 2003 and is based in Tokyo, Japan.

Alfresa Holdings Corporation
CountryJapan
Founded2003
IndustryMedical Distribution
SectorHealthcare
Employees12,452
CEORyuji Arakawa

Contact Details

Address:
1-1-3 Otemachi
Tokyo, 100-0004
Japan
Phone81 3 5219 5100
Websitealfresa.com

Stock Details

Ticker Symbol2784
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3126340003
SIC Code5122

Key Executives

NamePosition
Ryuji ArakawaChief Executive Officer